Glenview Trust’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.9M Sell
350,326
-20,862
-6% -$2.39M 0.61% 36
2025
Q4
$41.5M Buy
371,188
+125,828
+51% +$13.9M 0.64% 33
2025
Q3
$26.7M Buy
245,360
+13,628
+6% +$1.43M 0.42% 52
2025
Q2
$23.4M Sell
231,732
-83
-0% -$7.77K 0.4% 53
2025
Q1
$21.4M Buy
231,815
+16,896
+8% +$1.65M 0.42% 56
2024
Q4
$20.8M Buy
214,919
+7,145
+3% +$702K 0.39% 61
2024
Q3
$19.8M Buy
207,774
+1,467
+0.7% +$135K 0.38% 63
2024
Q2
$18.6M Buy
206,307
+1,798
+0.9% +$159K 0.37% 68
2024
Q1
$18.3M Buy
204,509
+5,873
+3% +$496K 0.39% 68
2023
Q4
$16.2M Buy
198,636
+61,358
+45% +$4.64M 0.4% 66
2023
Q3
$10.1M Buy
137,278
+49,197
+56% +$3.74M 0.28% 84
2023
Q2
$6.62M Buy
88,081
+18,965
+27% +$1.36M 0.18% 103
2023
Q1
$4.9M Buy
69,116
+59,055
+587% +$4.18M 0.15% 115
2022
Q4
$684K Buy
+10,061
New +$688K 0.02% 266

Other funds holding AVUS

Glenview Trust's AVUS Position: Q1 2026 in Review

Glenview Trust reduced its Avantis US Equity ETF (AVUS) stake by 5.6% in Q1 2026, selling an estimated $2.39M and leaving 350,326 shares worth $38.9M. The position accounts for 0.61% of the portfolio, ranked #36.

Glenview Trust first reported a position in AVUS in Q4 2022 and has held it in 14 quarters since. The position peaked at $41.5M in Q4 2025. 553 funds tracked by Wall St. Rank hold AVUS as of Q1 2026.

  • Glenview Trust held 350,326 shares of Avantis US Equity ETF worth $38.9M as of Q1 2026.
  • Glenview Trust sold 20,862 Avantis US Equity ETF shares in Q1 2026, an estimated $2.39M.
  • Avantis US Equity ETF made up 0.61% of Glenview Trust's portfolio in Q1 2026, its #36 holding.
  • Glenview Trust first reported a position in Avantis US Equity ETF in Q4 2022 and has held it in 14 quarters since.
  • Glenview Trust's Avantis US Equity ETF position peaked at $41.5M in Q4 2025.
  • 553 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.